Online first
Review article
Published online: 2025-02-13

open access

Page views 278
Article views/downloads 184
Get Citation

Connect on Social Media

Connect on Social Media

Approach for extracellular vesicles in renal therapeutics: involvement of microRNAs

Hend Ashour1, Hind Zafrah1, Mohamed H. Elsayed2

Abstract

Recently, special scientific efforts have been directed to investigate the role of small non-coding RNA (miRs) in different renal diseases. Extracellular vesicles (EVs) are small secretory vesicles released from almost all mammalian cells. EVs-miRs cargo plays a significant role in regulating various aspects of the biological machinery of the recipient cells. EVs-miRs may play an essential role in promoting cellular regenerative functions. miRs contained within the EVs fractions are capable of preserving their function throughout their journey from the cell of origin to the host cells. The current review discusses the role of EVs-miRs in different renal diseases as a novel approach for managing particular renal injuries. We tried to simplify the possible modulatory impact of miRs at the ultrastructural cellular pathological signaling, demonstrating the hazardous and the beneficial subtypes based on the previous research work. Further investigations are still needed in this regard, as miRs may have dual effects, as EVs-miR-23a could attenuate renal fibrosis through activation of Akt and inhibition of FoxO1 signaling. Whereas, EVs-miR-23a was upregulated by the hypoxia-inducible factor (HIF-1a) in the hypoxic TECs and activated macrophages to accelerate the renal inflammatory cytokine storm and promote interstitial fibrosis.

Article available in PDF format

View PDF Download PDF file

References

  1. Ashour H, Rashed L, Elkordy MA, et al. Remote liver injury following acute renal ischaemia-reperfusion: involvement of circulating exosomal miR-687 and regulation by thymoquinone. Exp Physiol. 2021; 106(11): 2262–2275.
  2. Brossa A, Fonsato V, Grange C, et al. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo. Int J Cancer. 2020; 147(6): 1694–1706.
  3. Bruno S, Porta S, Bussolati B. Extracellular vesicles in renal tissue damage and regeneration. Eur J Pharmacol. 2016; 790: 83–91.
  4. Cao D, Wang Y, Zhang Y, et al. Regulation of connective tissue growth factor expression by miR-133b for the treatment of renal interstitial fibrosis in aged mice with unilateral ureteral obstruction. Stem Cell Res Ther. 2021; 12(1): 171.
  5. Collino F, Pomatto M, Bruno S, et al. Exosome and microvesicle-enriched fractions isolated from mesenchymal stem cells by gradient separation showed different molecular signatures and functions on renal tubular epithelial cells. Stem Cell Rev Rep. 2017; 13(2): 226–243.
  6. Ding C, Zheng J, Wang Bo, et al. Exosomal microRNA-374b-5p from tubular epithelial cells promoted M1 macrophages activation and worsened renal ischemia/reperfusion injury. Front Cell Dev Biol. 2020; 8: 587693.
  7. Fang DYp, King HW, Li JYz, et al. Exosomes and the kidney: blaming the messenger. Nephrology (Carlton). 2013; 18(1): 1–10.
  8. Guan H, Peng R, Mao L, et al. Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomes. Exp Cell Res. 2020; 392(2): 112007.
  9. He J, He J, Min Li, et al. Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma. Int J Cancer. 2020; 146(4): 1052–1063.
  10. Ichii O, Horino T. MicroRNAs associated with the development of kidney diseases in humans and animals. J Toxicol Pathol. 2018; 31(1): 23–34.
  11. Jeon JS, Kim E, Bae YU, et al. microRNA in extracellular vesicles released by damaged podocytes promote apoptosis of renal tubular epithelial cells. Cells. 2020; 9(6).
  12. Jia Y, Zheng Z, Guan M, et al. Exendin-4 ameliorates high glucose-induced fibrosis by inhibiting the secretion of miR-192 from injured renal tubular epithelial cells. Exp Mol Med. 2018; 50(5): 1–13.
  13. Jiang L, Liu XQ, Ma Q, et al. hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells. FASEB J. 2019; 33(3): 3523–3535.
  14. Klein JD, Wang XH. Electrically stimulated acupuncture increases renal blood flow through exosome-carried miR-181. Am J Physiol Renal Physiol. 2018; 315(6): F1542–F1549.
  15. Li Q, Zhang C, Shi J, et al. High-phosphate-stimulated macrophage-derived exosomes promote vascular calcification via let-7b-5p/TGFBR1 axis in chronic kidney disease. Cells. 2022; 12(1).
  16. Li X, Liao J, Su X, et al. Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1. Theranostics. 2020; 10(21): 9561–9578.
  17. Li ZL, Lv LL, Tang TT, et al. HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation. Kidney Int. 2019; 95(2): 388–404.
  18. Liu W, Hu C, Zhang B, et al. Exosomal microRNA-342-5p secreted from adipose-derived mesenchymal stem cells mitigates acute kidney injury in sepsis mice by inhibiting TLR9. Biol Proced Online. 2023; 25(1): 10.
  19. Lopatina T, Grange C, Fonsato V, et al. Extracellular vesicles from human liver stem cells inhibit tumor angiogenesis. Int J Cancer. 2019; 144(2): 322–333.
  20. Lv LL, Feng Ye, Wu M, et al. Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 2020; 27(1): 210–226.
  21. Medica D, Franzin R, Stasi A, et al. Extracellular vesicles derived from endothelial progenitor cells protect human glomerular endothelial cells and podocytes from complement- and cytokine-mediated injury. Cells. 2021; 10(7).
  22. Meng L, Xing Z, Guo Z, et al. Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting . Aging (Albany NY). 2021; 13(7): 9613–9626.
  23. Nargesi AA, Lerman LO, Eirin A. Mesenchymal stem cell-derived extracellular vesicles for renal repair. Curr Gene Ther. 2017; 17(1): 29–42.
  24. Oosthuyzen W, Scullion KM, Ivy JR, et al. Vasopressin regulates extracellular vesicle uptake by kidney collecting duct cells. J Am Soc Nephrol. 2016; 27(11): 3345–3355.
  25. Pan T, Jia P, Chen N, et al. Delayed remote ischemic preconditioning confersrenoprotection against septic acute kidney injury via exosomal miR-21. Theranostics. 2019; 9(2): 405–423.
  26. Pang P, Abbott M, Chang SL, et al. Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks. Kidney Int. 2017; 91(1): 129–143.
  27. van der Pol E, Böing AN, Harrison P, et al. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012; 64(3): 676–705.
  28. Qin Z, Hu H, Sun W, et al. miR-224-5p contained in urinary extracellular vesicles regulates PD-L1 expression by inhibiting cyclin D1 in renal cell carcinoma cells. Cancers (Basel). 2021; 13(4).
  29. Qiu G, Zheng G, Ge M, et al. Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs. Stem Cell Res Ther. 2018; 9(1): 320.
  30. Qu Le, Ding J, Chen C, et al. Exosome-Transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016; 29(5): 653–668.
  31. Rashed LA, Elattar S, Eltablawy N, et al. Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy. Biochem Cell Biol. 2018; 96(5): 564–571.
  32. Šibíková M, Živný J, Janota J. Cell membrane-derived microvesicles in systemic inflammatory response. Folia Biol (Praha). 2018; 64(4): 113–124.
  33. Tsai YC, Kuo MC, Hung WW, et al. Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer. Cell Commun Signal. 2023; 21(1): 10.
  34. Wang Bo, Yao K, Huuskes BM, et al. Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther. 2016; 24(7): 1290–1301.
  35. Wang C, Zhu G, He W, et al. BMSCs protect against renal ischemia-reperfusion injury by secreting exosomes loaded with miR-199a-5p that target BIP to inhibit endoplasmic reticulum stress at the very early reperfusion stages. FASEB J. 2019; 33(4): 5440–5456.
  36. Wang H, Wang B, Zhang A, et al. Exosome-mediated miR-29 transfer reduces muscle atrophy and kidney fibrosis in mice. Mol Ther. 2019; 27(3): 571–583.
  37. Wang Lu, Yang G, Zhao D, et al. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p. Mol Cancer. 2019; 18(1): 86.
  38. Wang Y, Guo YiF, Fu GP, et al. Protective effect of miRNA-containing extracellular vesicles derived from mesenchymal stromal cells of old rats on renal function in chronic kidney disease. Stem Cell Res Ther. 2020; 11(1): 274.
  39. Wang Y, Liu J, Wang H, et al. Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through the NLRP3 signaling pathway. Stem Cells. 2023; 41(4): 368–383.
  40. Xiao H, Shi J. Exosomal circular RNA_400068 promotes the development of renal cell carcinoma via the miR‑210‑5p/SOCS1 axis. Mol Med Rep. 2020; 22(6): 4810–4820.
  41. Chen Y, Yang X, Feng M, et al. Bone marrow mesenchymal stem cell-derived exosomes protect podocytes from HBx-induced ferroptosis. PeerJ. 2023; 11: e15314.
  42. Yoon YM, Lee JH, Song KH, et al. Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins. J Pineal Res. 2020; 68(3): e12632.
  43. Yu W, Zeng H, Chen J, et al. miR-20a-5p is enriched in hypoxia-derived tubular exosomes and protects against acute tubular injury. Clin Sci (Lond). 2020; 134(16): 2223–2234.
  44. Yu Y, Chen M, Guo Q, et al. Human umbilical cord mesenchymal stem cell exosome-derived miR-874-3p targeting RIPK1/PGAM5 attenuates kidney tubular epithelial cell damage. Cell Mol Biol Lett. 2023; 28(1): 12.
  45. Zhang A, Li M, Wang B, et al. miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk. J Cachexia Sarcopenia Muscle. 2018; 9(4): 755–770.
  46. Zhang A, Wang H, Wang B, et al. Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease. FASEB J. 2019; 33(12): 13590–13601.
  47. Zhang C, Shang Y, Chen X, et al. Supramolecular nanofibers containing arginine-glycine-aspartate (RGD) peptides boost therapeutic efficacy of extracellular vesicles in kidney repair. ACS Nano. 2020; 14(9): 12133–12147.
  48. Zhang R, Zhu Y, Li Y, et al. Human umbilical cord mesenchymal stem cell exosomes alleviate sepsis-associated acute kidney injury via regulating microRNA-146b expression. Biotechnol Lett. 2020; 42(4): 669–679.
  49. Zhang X, Wang N, Huang Y, et al. Extracellular vesicles from three dimensional culture of human placental mesenchymal stem cells ameliorated renal ischemia/reperfusion injury. Int J Artif Organs. 2022; 45(2): 181–192.
  50. Zhang Y, Ma S, Zhang J, et al. MicroRNA-142-3p promotes renal cell carcinoma progression by targeting RhoBTB3 to regulate HIF-1 signaling and GGT/GSH pathways. Sci Rep. 2023; 13(1): 5935.
  51. Zhao T, Jin Q, Kong L, et al. microRNA-15b-5p shuttled by mesenchymal stem cell-derived extracellular vesicles protects podocytes from diabetic nephropathy via downregulation of VEGF/PDK4 axis. J Bioenerg Biomembr. 2022; 54(1): 17–30.
  52. Zheng H, Ji J, Zhao T, et al. Exosome‑encapsulated miR‑26a attenuates aldosterone‑induced tubulointerstitial fibrosis by inhibiting the CTGF/SMAD3 signaling pathway. Int J Mol Med. 2023; 51(2).
  53. Zhou Y, Fang Li, Yu Y, et al. Erythropoietin protects the tubular basement membrane by promoting the bone marrow to release extracellular vesicles containing tPA-targeting miR-144. Am J Physiol Renal Physiol. 2016; 310(1): F27–F40.
  54. Zhou Y, Li P, Goodwin AJ, et al. Exosomes from endothelial progenitor cells improve the outcome of a murine model of sepsis. Mol Ther. 2018; 26(5): 1375–1384.
  55. Zhu G, Pei L, Lin F, et al. Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR-199a-3p. J Cell Physiol. 2019; 234(12): 23736–23749.
  56. Zou XY, Yu Y, Lin S, et al. Comprehensive miRNA analysis of human umbilical cord-derived mesenchymal stromal cells and extracellular vesicles. Kidney Blood Press Res. 2018; 43(1): 152–161.